Realbotix closes $7-million private placement

Executive Summary

• Realbotix Corp. has closed a brokered, upsized private placement of 14 million units at $0.50 per unit, raising aggregate gross proceeds of $7 million.
• The company intends to use the net proceeds to advance the engineering, design, and commercialization of its AI-powered humanoid robots, as well as for working capital and general corporate purposes.
• The offering was completed pursuant to the Listed Issuer Financing Exemption, meaning the securities are not subject to a hold period under Canadian securities laws.

Key Details

• Transaction Structure: Brokered private placement of 14,000,000 units.
• Price: $0.50 per unit.
• Gross Proceeds: $7,000,000 CAD.
• Unit Composition: Each unit consists of one common share and one common share purchase warrant.
• Warrant Terms:
  • Each warrant entitles the holder to acquire one common share.
  • Exercise Price: $0.75 per warrant share.
  • Expiration Date: October 24, 2030.
  • Subject to adjustment in certain events.
• Agents:
  • Sole Bookrunner and Agent: A.G.P. Canada Investments ULC.
  • Sole U.S. Placement Agent: A.G.P./Alliance Global Partners.
• Use of Proceeds: Advancing engineering, design, and commercialization of AI-powered humanoid robots; working capital; and general corporate purposes.
• Regulatory Basis: Offered pursuant to Part 5A of National Instrument 45-106 and Coordinated Blanket Order 45-935 (Listed Issuer Financing Exemption).
• Hold Periods:
  • Investor Securities: No hold period under applicable Canadian securities laws.
  • Broker Warrants: Subject to a four-month hold period.
• Agent Compensation:
  • Cash Commission: 7.0% of the offering amount.
  • Warrants Issued: 980,000 non-transferable warrants to the agent.
  • Broker Warrant Terms: Exercise price of $0.75, expiring October 24, 2030.
• Offering Document: Amended and restated offering document dated October 22, 2025, available on SEDAR+ and the company website.
• Exchange Approval: The offering remains subject to final acceptance of the TSX Venture Exchange.

Notable Quotes

• "We are pleased to successfully complete this offering, which provides Realbotix with the capital to achieve our objectives for the foreseeable future. This strengthened financial position empowers us to accelerate growth across our products, services and target markets. With a strong balance sheet, we are confident in our ability to deploy this capital strategically to deliver strong returns on investment." — Andrew Kiguel, Executive Chairman and Chief Executive Officer